Cipher Pharmaceuticals Inc T.CPH

Alternate Symbol(s): CPHRF

Healthcare

Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products, mainly in dermatology. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products in Canada, the United States, and South America. Its dermatology products include Actikerall, Epuris, and Vaniqa. Its hospital acute care products include Aggrastat and Brinavess. Its out-licensed products include Absorica, ConZip and Lipofen. Durela is its specialty medicine. Its product pipeline includes MOB-015, CF-101, and DTR-001. It delivers novel products to healthcare professionals and patients in Canada in a range of therapeutic areas, including dermatology, women’s health, urology and others. It also has the Natroba operations and global product rights to Natroba and its authorized generic Spinosad, a topical treatment for both head lice and scabies.

TSX:CPH - Post by User

Cipher Pharmaceuticals Inc

Bullboard Posts

Comment by pabalooon Apr 13, 2020 3:13pm

62 Views

Post# 30904326

RE:RE:Market Meltdown?!!!

Prepare for round 2. Now there is no new money coming for future bailouts and companies are going to realize there is no V shape recovery coming. In fact we will see this drag on way longer than anyone modeled and if the US government wants to rush people back to work before it's eradicated get ready for a resurgence and depression. I took everything out of the market except Cipher only because its going to pop soon I hope and it's drastically being wiped out.

Bullboard Posts

Canadian psychedelic stock to supply MDMA to Yale